BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/28/2026 8:32:54 AM | Browse: 0 | Download: 0
 |
Received |
|
2025-10-09 17:32 |
|
Peer-Review Started |
|
2025-10-09 17:32 |
|
First Decision by Editorial Office Director |
|
2025-10-28 09:46 |
|
Return for Revision |
|
2025-10-28 09:46 |
|
Revised |
|
2025-11-01 03:45 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-12-23 02:34 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-12-23 03:10 |
|
Articles in Press |
|
2025-12-23 03:10 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-02-13 03:59 |
|
Publish the Manuscript Online |
|
2026-02-28 08:32 |
| ISSN |
2220-3206 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Psychiatry |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Critical Commentary on Initial Lurasidone Dosing Strategies in Acute Schizophrenia
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hao-Yu Xing and Juan Yan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Juan Yan, Manager, MD, Professor, Graduate School, Zhejiang Chinese Medical University, No. 305 Tianmushan Road, Xihu District, Hangzhou 311402, Zhejiang Province, China. 294162939@qq.com |
| Key Words |
Lurasidone; Schizophrenia; Initial dose; Safety; Efficacy; Pragmatic trial |
| Core Tip |
Liu et al provide evidence challenging the conventional "start low, go slow" approach for lurasidone in acute schizophrenia. Their trial suggests that initiating treatment at 80 mg/day is as safe as 40 mg/day, and may offer faster symptom control. This commentary discusses these findings in the context of prior dosing studies, emphasizing the need for tailored strategies while noting methodological constraints. |
| Publish Date |
2026-02-28 08:32 |
| Citation |
Xing HY, Yan J. Critical Commentary on Initial Lurasidone Dosing Strategies in Acute Schizophrenia. World J Psychiatry 2026; 16(3): 114882 |
| URL |
https://www.wjgnet.com/2220-3206/full/v16/i3/114882.htm |
| DOI |
https://dx.doi.org/10.5498/wjp.v16.i3.114882 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
